Metraipolis › archive › dc_edf9c6603471
Case Report: Complete response to the novel NaPi2b-targeting ADC YL205 in heavily pretreated platinum-resistant ovarian cancer — Europe PMC PMID:42255229
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42255229
- DOI
- 10.3389/fonc.2026.1781961
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T09:19:53.795Z
- SHA-256 of the archived text
cba16b14b520151ea1d77e25eb62cd03c811dd5ba22643e21d31c9fdea379605- Stable URL of this page
https://metraipolis.com/documento/dc_edf9c6603471
How to cite
Case Report: Complete response to the novel NaPi2b-targeting ADC YL205 in heavily pretreated platinum-resistant ovarian cancer — Europe PMC PMID:42255229 — Europe PMC (en), https://europepmc.org/article/MED/42255229 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_edf9c6603471 (Metraipolis archive dc_edf9c6603471, sha256 cba16b14b520151ea1d77e25eb62cd03c811dd5ba22643e21d31c9fdea379605)
BibTeX
@misc{dcedf9c6603471,
title = {Case Report: Complete response to the novel NaPi2b-targeting ADC YL205 in heavily pretreated platinum-resistant ovarian cancer — Europe PMC PMID:42255229},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42255229},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_edf9c6603471; sha256 cba16b14b520151ea1d77e25eb62cd03c811dd5ba22643e21d31c9fdea379605},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42255229. Agents can read the archived copy with the MCP tool read_document.